Thrivent Financial For Lutherans Eli Lilly & CO Transaction History

Thrivent Financial For Lutherans

$49.6 Billion
Q2 2024

A detailed history of Thrivent Financial For Lutherans transactions in Eli Lilly & CO stock. As of the latest transaction made, Thrivent Financial For Lutherans holds 365,582 shares of LLY stock, worth $321 Million. This represents 0.67% of its overall portfolio holdings.

Number of Shares

365,582

Previous 232,107 57.51%

Holding current value

$321 Million

Previous $181 Million 83.3%

% of portfolio

0.67%

Previous 0.36%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$724.87 - $909.04 $96.8 Million - $121 Million	133,475 Added 57.51%	365,582 $331 Million
Q1 2024 May 14, 2024	BUY	$592.2 - $792.28 $74 Million - $99 Million	124,984 Added 116.67%	232,107 $181 Million
Q4 2023 Feb 14, 2024	SELL	$525.19 - $619.13 $3.65 Million - $4.31 Million	-6,956 Reduced 6.1%	107,123 $62.4 Million
Q3 2023 Nov 14, 2023	SELL	$434.7 - $599.3 $2.56 Million - $3.52 Million	-5,878 Reduced 4.9%	114,079 $61.3 Million
Q2 2023 Aug 14, 2023	BUY	$350.74 - $468.98 $14.4 Million - $19.2 Million	40,963 Added 51.86%	119,957 $56.2 Million
Q1 2023 May 17, 2023	BUY	$310.63 - $364.82 $240,738 - $282,735	775 Added 0.99%	78,994 $27.1 Million
Q4 2022 Feb 08, 2023	SELL	$321.55 - $374.67 $2.91 Million - $3.39 Million	-9,048 Reduced 10.37%	78,219 $28.6 Million
Q3 2022 Nov 14, 2022	SELL	$296.48 - $337.87 $1.04 Million - $1.18 Million	-3,504 Reduced 3.86%	87,267 $28.3 Million
Q2 2022 Aug 16, 2022	SELL	$278.73 - $327.27 $16.3 Million - $19.2 Million	-58,515 Reduced 39.2%	90,771 $29.4 Million
Q1 2022 May 13, 2022	SELL	$234.69 - $291.66 $1.56 Million - $1.94 Million	-6,637 Reduced 4.26%	149,286 $42.1 Million
Q4 2021 Feb 16, 2022	SELL	$224.85 - $279.04 $9.28 Million - $11.5 Million	-41,257 Reduced 20.92%	155,923 $39.2 Million
Q3 2021 Nov 15, 2021	SELL	$221.6 - $272.71 $26,370 - $32,452	-119 Reduced 0.06%	197,180 $45.5 Million
Q2 2021 Sep 24, 2021	BUY	$180.55 - $233.54 $12.9 Million - $16.7 Million	71,400 Added 56.71%	197,299 $45.3 Million
Q2 2021 Aug 19, 2021	SELL	$180.55 - $233.54 $13.7 Million - $17.7 Million	-75,987 Reduced 37.64%	125,899 $28.9 Million
Q1 2021 May 17, 2021	SELL	$164.32 - $212.72 $8.66 Million - $11.2 Million	-52,716 Reduced 20.71%	201,886 $37.7 Million
Q4 2020 Feb 16, 2021	SELL	$130.46 - $172.63 $7.87 Million - $10.4 Million	-60,326 Reduced 19.16%	254,602 $43 Million
Q3 2020 Nov 10, 2020	BUY	$146.22 - $169.13 $12.8 Million - $14.8 Million	87,658 Added 38.57%	314,928 $46.6 Million
Q2 2020 Aug 12, 2020	BUY	$136.42 - $164.18 $11.9 Million - $14.3 Million	87,077 Added 62.11%	227,270 $35.4 Million
Q1 2020 May 15, 2020	BUY	$119.05 - $147.35 $6.48 Million - $8.02 Million	54,401 Added 63.41%	140,193 $19.4 Million
Q4 2019 Feb 13, 2020	SELL	$106.92 - $132.43 $179,091 - $221,820	-1,675 Reduced 1.92%	85,792 $11.3 Million
Q3 2019 Nov 14, 2019	BUY	$106.79 - $116.16 $47,307 - $51,458	443 Added 0.51%	87,467 $9.78 Million
Q2 2019 Aug 13, 2019	SELL	$110.79 - $129.32 $6.84 Million - $7.99 Million	-61,755 Reduced 41.51%	87,024 $9.64 Million
Q1 2019 May 14, 2019	SELL	$111.31 - $131.02 $21.6 Million - $25.5 Million	-194,494 Reduced 56.66%	148,779 $19.3 Million
Q4 2018 Feb 15, 2019	BUY	$105.9 - $118.64 $839,681 - $940,696	7,929 Added 2.36%	343,273 $39.5 Million
Q3 2018 Nov 15, 2018	SELL	$85.86 - $107.31 $863,579 - $1.08 Million	-10,058 Reduced 2.91%	335,344 $36 Million
Q2 2018 Aug 14, 2018	SELL	$75.7 - $86.88 $90,234 - $103,560	-1,192 Reduced 0.34%	345,402 $29.5 Million
Q1 2018 May 08, 2018	BUY	$74.21 - $87.6 $15.3 Million - $18.1 Million	206,748 Added 147.84%	346,594 $26.8 Million
Q4 2017 Feb 14, 2018	BUY	$81.94 - $87.89 $3.89 Million - $4.17 Million	47,461 Added 51.37%	139,846 $11.8 Million
Q3 2017 Nov 14, 2017	BUY	$77.07 - $85.54 $7.12 Million - $7.9 Million	92,385	92,385 $7.9 Million

Others Institutions Holding LLY

# of Institutions

3,872

Shares Held

751M

Call Options Held

6.34M

Put Options Held

7.97M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $834B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Thrivent Financial For Lutherans, based on Form 13F filings with the SEC.

News

Stay updated on Thrivent Financial For Lutherans with notifications on news.

Account

Thrivent Financial For Lutherans Eli Lilly & CO Transaction History